Quest Diagnostics Inc Cash and Restricted Cash
Quest Diagnostics Inc (DGX) had Cash and Restricted Cash of $626.00 million as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-07-23
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $626.00M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $393.00M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $420.00M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $432.00M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $626.00M 10-Q · filed 2026-07-23 |
| 2026-03-31 | $393.00M 10-Q · filed 2026-04-22 |
| 2025-12-31 | $420.00M 10-Q · filed 2026-07-23 |
| 2025-09-30 | $432.00M 10-Q · filed 2025-10-21 |
| 2025-06-30 | $319.00M 10-Q · filed 2026-07-23 |
| 2025-03-31 | $188.00M 10-Q · filed 2026-04-22 |
| 2024-12-31 | $549.00M 10-Q · filed 2026-07-23 |
| 2024-09-30 | $764.00M 10-Q · filed 2025-10-21 |
| 2024-06-30 | $271.00M 10-Q · filed 2025-07-23 |
| 2024-03-31 | $474.00M 10-Q · filed 2025-04-23 |
| 2023-12-31 | $686.00M 10-K · filed 2026-02-26 |
| 2023-09-30 | $143.00M 10-Q · filed 2024-10-23 |
| 2023-06-30 | $126.00M 10-Q · filed 2024-07-24 |
| 2023-03-31 | $175.00M 10-Q · filed 2024-04-24 |
| 2022-12-31 | $315.00M 10-K · filed 2026-02-26 |
| 2022-09-30 | $700.00M 10-Q · filed 2023-10-25 |
| 2022-06-30 | $790.00M 10-Q · filed 2023-07-27 |
| 2022-03-31 | $712.00M 10-Q · filed 2023-04-28 |
| 2021-12-31 | $872.00M 10-K · filed 2025-02-20 |
| 2021-09-30 | $987.00M 10-Q · filed 2022-10-21 |
| 2021-06-30 | $560.00M 10-Q · filed 2022-07-22 |
| 2021-03-31 | $1.23B 10-Q · filed 2022-04-22 |
| 2020-12-31 | $1.16B 10-K · filed 2024-02-22 |
| 2020-09-30 | $1.60B 10-Q · filed 2021-10-22 |
| 2020-06-30 | $988.00M 10-Q · filed 2021-07-23 |
| 2020-03-31 | $342.00M 10-Q · filed 2021-04-23 |
| 2019-12-31 | $1.19B 10-K · filed 2023-02-21 |
| 2019-09-30 | $434.00M 10-Q · filed 2020-10-23 |
| 2019-06-30 | $273.00M 10-Q · filed 2020-07-24 |
| 2019-03-31 | $464.00M 10-Q · filed 2020-05-04 |
| 2018-12-31 | $135.00M 10-K · filed 2022-02-28 |
| 2018-09-30 | $263.00M 10-Q · filed 2019-10-23 |
| 2018-06-30 | $132.00M 10-Q · filed 2019-07-24 |
| 2018-03-31 | $124.00M 10-Q · filed 2019-04-24 |
| 2017-12-31 | $137.00M 10-K · filed 2021-02-22 |
| 2017-09-30 | $350.00M 10-Q · filed 2018-10-24 |
| 2017-06-30 | $314.00M 10-Q · filed 2018-07-25 |
| 2017-03-31 | $367.00M 10-Q · filed 2018-04-20 |
| 2016-12-31 | $384.00M 10-K · filed 2020-02-20 |
| 2015-12-31 | $133.00M 10-K · filed 2019-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |